Purchase Order HHSN272201700494P
- Not listed
- This is a $13,451.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian federal agency. The contract is for the delivery of fetal bovine serum from Gemini Bioproducts LLC, a for-profit manufacturer and supplier of cell culture media, sera, and other reagents. This award does not have a set-aside designation. Gemini Bioproducts has previously received numerous orders...
- This federal contract award to Gemini Bioproducts LLC, a for-profit manufacturer of cell culture media and other biomedical research supplies, is for the delivery of fetal bovine serum under Purchase Order HHSN272201001085P. The $5,027.40 firm fixed price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for the supply of BENCHMARK fetal bovine serum. Gemini Bioproducts has previously received numerous...
- This $3,501.23 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Gemini Bioproducts LLC. Gemini Bioproducts is a leading manufacturer and supplier of cell culture media, sera, and other reagents to the scientific community, including academic research and the biotechnology, cell and gene therapy, and biopharma industries. The contract is to provide fetal bovine serum, viral...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Gemini Bioproducts LLC. The $57,375.00 firm-fixed-price purchase order was for the delivery of 500 mL of benchmark fetal bovine serum, a critical cell culture component used in biomedical research. This order is part of NIAID's ongoing procurement of specialized cell culture media and reagents to support its diverse scientific initiatives....
- This $6,336 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Gemini Bioproducts LLC, a leading manufacturer and supplier of cell culture media, sera, and other reagents to the scientific community. The contract is for the delivery of Benchmark FBS - 500mL, catalog #100106. Gemini Bioproducts has received numerous prior awards from NIH to supply fetal bovine serum for cell...
- This is a federal contract award from the Department of Health and Human Services National Institutes of Health National Cancer Institute to Gemini Bioproducts LLC, a manufacturer of cell culture media, sera, and other reagents. The contract is for the delivery of GEMCELL US ORIGIN FETAL BOVINE SERUM, with a firm fixed price and a potential value of $244,591.50. The contract does not have a set-aside designation. Gemini Bioproducts has received numerous previous awards from the National...
- This is a federal contract award to Gemini Bioproducts LLC, a leading manufacturer and supplier of cell culture media, sera, and other reagents, by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The contract has a total ceiling value of $26,000.00 and is for the supply of biomaterial products. The contract type is a firm fixed-price purchase order, with an ultimate completion date of October 21, 2015. This award is not associated...
- This federal contract award, valued at $9,186.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Gemini Bioproducts LLC, a leading manufacturer and supplier of cell culture media, sera, and other reagents. The contract is for the delivery of 500 mL bottles of heat-inactivated fetal bovine serum, a critical component for cell culture maintenance across biomedical research and development. The award is not associated with a larger contract vehicle, and there was...
- This $61,728 firm fixed price purchase order was awarded on September 11, 2024 to Gemini Bioproducts LLC, a for-profit manufacturer of cell culture media, sera, and other reagents. The contract supports the National Institutes of Health (NIH) Clinical Center with the supply of GemCell Plus Xeno-Free Lot H423031 products. Gemini Bioproducts has received prior sole source awards from NIH and the U.S. Department of Agriculture to provide specialized cell culture and viral transport media...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Gemini Bioproducts LLC. The $14,745.00 award is for in vitro diagnostic substances, reagents, test kits, and sets. Gemini Bioproducts is a leading manufacturer and supplier of cell culture media, sera, and other reagents to the scientific community across academic research, biotechnology, cell and gene therapy, and...
This firm fixed-price purchase order was awarded to Gemini Bioproducts LLC, a for-profit manufacturer of goods, by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. The $102,116.06 contract is for the delivery of fetal bovine serum, and is designated as a Total Small Business set-aside. Gemini Bioproducts is a leading supplier of cell culture media, sera, and other reagents to the scientific community, including academic research and the biotechnology, cell and gene therapy, and biopharma industries. The company has previously received numerous awards from the National Institutes of Health and the Department of Agriculture's Animal and Plant Health Inspection Service Veterinary Services division to provide fetal bovine serum and other products in support of biomedical research and emergency response efforts. Gemini Bioproducts also holds a multiple-award indefinite delivery contract from the Federal Emergency Management Agency, valued at up to $200 million, to provide testing supplies like swabs and media in support of the federal COVID-19 response.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($472) | 3/9/22 | |
| Not listed | Not listed | $102.6k | 3/24/17 |